美国数字药房市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPRE00030057
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 100
Buy Now

US Digital Pharmacy Market to Grow at a CAGR of 17.25% to reach US$ 2,40,216.87 million from 2022 to 2030

Buy Now

美国数字药房市场规模预计将从2022年的672.4293亿美元增长到2030年的2402.1687亿美元;预计 2022 年至 2030 年复合年增长率为 17.25%。
分析师观点
美国数字药房市场分析解释了市场驱动因素,例如 COVID-19 大流行期间在线购买处方药的激增以及越来越倾向于在线平台。此外,基于网络的集成在线药房界面预计将成为 2022-2030 年市场的新趋势。根据药品类型,美国数字药房市场分为处方药和非处方药。处方药细分市场在 2022 年占据更大的市场份额,预计 2022-2030 年该细分市场的复合年增长率将达到 17.83%。美国数字药房市场按产品细分为个人护理、维生素和补充剂、药物和治疗以及其他产品。药物和治疗领域在 2022 年占据了更大的市场份额,预计该领域在预测期内将实现更高的复合年增长率。根据平台,美国数字药房市场分为基于应用程序和基于网站的。基于应用程序的细分市场预计将在 2022 年至 2030 年期间占据最大市场份额。根据性别,美国数字药房市场分为男性和女性。预计 2022 年至 2030 年,女性细分市场将占据美国数字药房市场的最大份额。
数字药房是一个基于互联网的药品销售平台,作为独立的互联网网站运营,实体药房的在线分支机构,或代表药房之间合作伙伴关系的网站。

市场见解
COVID-19 大流行期间在线购买处方药的激增推动了美国数字药房市场
根据 ASOP 全球基金会 2020 年发布的报告,由于便利和成本效益,近 50% 的美国人口在网上购买药品。数字药房及其采用的好处不断增加,导致药房按需需求增加。 Abacus Data 对 1,500 名美国消费者进行的另一项调查显示,2020 年,十分之四的美国人 (42%) 在网上购买药品,从 2020 年到 2021 年,网上购买药品的人数增加了 7%。此外,购买趋势美国表示,美国人在网上购买一系列处方药,范围从治疗慢性和持续性疾病的产品(占所有购买量的 23%),包括高血压、哮喘和糖尿病,到癌症和激素替代治疗药物等专业处方药(每项均占所有购买量的 11%)。此外,64%的人在2021年首次在线购买药品,并打算在疫情结束后继续在线购买药品。人们对网上购买药品的偏好主要是因为购买的便利性、产品的可及性以及处方药成本的降低(折扣、特价等)。 healthinsurance.com 进行的一项调查显示,2021 年美国医疗保险受益人的远程医疗使用量增加了 340%。增加的用户中有 33% 表示,在新冠肺炎 (COVID-19) 疫情期间,他们更喜欢通过在线药房订购处方药大流行。因此,网上购买处方药数量的增加、数字药剂师数量的增加,加上电子商务行业的快速发展以及消费者行为向网上购买的大规模转变,有利于美国数字药房市场的增长。
未来趋势
集成的基于网络的在线药房界面成为主要趋势
集成的电子医疗保健系统与药剂师和患者可以访问的基于网络的药房界面相结合,可能会成为美国数字化的新趋势未来几年的医药市场。在线药店为购买药品的人们提供在线支持的程序就是此类界面的一个显着例子。例如,服用他汀类药物作为治疗一部分的患者可能会停止服药或表现出不规律服药,从而加速在线药房平台的发展。与经过培训的药房团队成员进行提醒和实时聊天,为服用他汀类处方药的人提供依从性支持,有助于避免剂量的中断。
报告细分和范围
基于药物类型的见解
基于药品类型方面,美国数字药房市场分为处方药和非处方药。处方药细分市场将在 2022 年占据更大的市场份额,预计该细分市场在预测期内的复合年增长率将达到 17.83%。医生在线填写数字处方并通过互联网将其直接发送到处方中心。处方中心是发放和处理药品、婴儿食品和医疗设备的电子数据库。处方默认是公开的,但只能由相关医生更改。在私人处方中,仅允许患者购买处方药,而在授权处方中,处方药可以由患者或患者在门户网站上授权的人在药房购买。购买处方药的个人需要向药剂师出示身份证件,包括照片和身份证号码。如果药品是为他人购买的,购买者还必须知道他们的个人身份证号码。买家验证后,药剂师将根据买家的识别码(处方中提到的)在处方中心找到正确的处方。
基于产品的见解
根据产品,美国数字药房市场细分为个人护理、维生素和补充剂、药物和治疗以及其他产品。药物和治疗领域进一步分为性健康、神经系统疾病、心脏保健、糖尿病、减肥等。药物和治疗领域在 2022 年占据了更大的市场份额,预计该领域在预测期内的复合年增长率将达到 17.87%。 Heartcare 在美国数字药房药品和治疗领域市场中占据最大份额。据美国心力衰竭协会称,2020 年美国报告称,由于缺乏护理协调,两次或多次入院的心力衰竭患者数量有所增加。这是由于缺乏一致的提供者造成的,如下护理,以及在家跟踪血压和体重的能力。美国心力衰竭协会还透露,药物是再入院的主要原因。通过数字药房可以有效评估、诊断、监测和跟踪包括心血管疾病在内的健康问题。使用通过可穿戴设备、血压和脉搏监测设备生成的患者数据;心电图;睡眠参数;脉搏血氧仪;等,有助于了解健康。数字医学能够及时有效地解释诊断数据,从而能够采取最佳治疗。为了正确识别风险因素并制定切实可行的方法来改进预防措施,将使用远程监控工具和优化的预防方案以及精准医学数据。远程药房具有经过充分证明的临床疗效和成本效益,但将这些服务纳入医疗保健模式可能会为改善心血管筛查和护理提供独特的机会。
他汀类药物可以减少包括死亡率在内的几种主要不良心血管事件。 COVID-19 大流行促进了远程医疗在初级保健和高脂血症治疗中的快速采用,极大地改变了护理服务。根据 2021 年国家医学图书馆发表的一篇文章,由于 COVID-19,亲自就诊减少,但远程医疗就诊增加。研究发现,2020 年 4 月和 5 月期间,远程医疗就诊期间的他汀类药物处方率高于亲自就诊的比例。由于高脂血症并不总是需要体检来进行管理,因此远程医疗服务可能是高脂血症管理的有效用例。此外,与面对面会议相比,远程医疗就诊可能使临床医生能够花更多的时间来解决高脂血症等慢性病。
基于平台的见解
就平台而言,美国数字药房市场分为基于应用程序和基于应用程序的平台基于网站。基于应用程序的应用程序进一步细分为远程医疗药房应用程序、药物管理应用程序、健康和保健应用程序、复合药房应用程序等。基于应用程序的细分市场将在 2022 年占据更大的市场份额,预计该细分市场在预测期内的复合年增长率将达到 17.60%。预计 2022 年至 2030 年期间,远程医疗药房应用程序将占据基于应用程序细分市场的最大份额。可以从任何地方通过远程医疗应用程序访问虚拟医疗保健。根据 CDC 2021 年发布的数据,2020 年有 37.0% 的成年人使用远程医疗,包括医疗服务提供者就诊、在线处方和心理健康服务。最好的远程医疗应用程序可以免费下载并且易于使用,而且它们通常完全涵盖保险服务。远程医疗药房应用程序的一些示例包括 Hims & Hers、GoodRx、K Health 和 Doctor on Demand。 GoodRx 提供低成本就诊、通过邮件轻松补充处方以及无需健康保险的就诊等服务。
基于性别的见解
按性别划分,市场分为男性和女性。女性细分市场在 2022 年占据更大的市场份额,预计同一细分市场在预测期内的复合年增长率将达到 17.64%。
美国数字药房市场,按药物类型 – 2022 年和 2030 年

国家分析
美国数字药房市场预计将从 2022 年的 672.4293 亿美元增至 2030 年的 2402.1687 亿美元。预计 2022 年至 2030 年,该市场将以 17.25% 的复合年增长率增长。市场的增长归因于 COVID-19 大流行期间在线购买处方药的激增以及人们越来越倾向于在线平台。然而,在线药房运营中的非法行为阻碍了市场增长。
美国的几家初创企业已进入在线药房领域,并获得了大量风险投资资金。亚马逊等电子商务巨头已通过合作伙伴关系进入这一领域,而许多实体店也正在推出在线服务。美国的小型药店和经销商建立了网上商店,并报告了小规模的网上销售。在线平台和电子商务的普及热潮引发了美国药房[处方药和非处方药 (OTC)] 的数字化。
Nimble 以前是一家传统的实体药房,现在正在适应在线状态。该公司从 Y Combinator、红杉资本、DAG Ventures、First Round Capital 和 Khosla Ventures 筹集了约 6000 万美元的资金。它还寻求与实体药店合作提供送货服务。 2020年,沃尔玛收购了初创公司CareZone,并购买了其处方管理技术,以使沃尔玛的在线渠道更具竞争力。 CareZone 移动应用程序可帮助个人和家庭管理各种慢性疾病和药物。家庭可以快速、方便地访问他们的保险信息并扫描标签。通过此次收购,沃尔玛计划增强其数字健康和保健工具。
美国大多数人居住在社区药房 5 英里范围内,但农村和城市患者很难获得药房服务。美国农业部表示,影响药物可及性的一些因素包括全国范围内的药房关闭、交通问题、残疾相关问题和经济挑战,这些因素导致了药房沙漠。 《美国医学会杂志》2023 年发表的一项研究报告称,采用远程药房政策的州减少了药房沙漠,而且远程药房实际上比传统药房更接近医疗需求较高的人群。目前美国有28个州允许远程药房实施,各州的状态和法规各不相同。
人工智能(AI)和机器学习的融合使得用药监测的自动化、智能提醒和个性化治疗建议成为可能。此外,增强现实(AR)和虚拟现实(VR)技术可以增强远程药房客户的体验。因此,随着先进通信平台的出现,远程药房有可能彻底改变药物配药、咨询和患者护理,进而满足对便捷医疗服务不断增长的需求。
该报告介绍了美国数字药房的领先参与者市场。其中包括 Amazon.com Inc、Goodrx Holdings Inc、The Cigna Group、CVS Health Corp、Walmart Inc、Hims & Hers Health Inc、Roman Health Pharmacy LLC、Apex Pharmacy Inc、LloydsPharmacy Ltd、Pharmacy2U Ltd、Docmorris NV 和 Truepill。< br>2020年8月,亚马逊公司宣布在印度推出在线药房,在班加罗尔市提供服务。这是这家电子商务巨头扩大其在关键增长市场影响力的最新举措。亚马逊药房将提供非处方药和处方药以及基本保健设备和传统印度草药。 2023 年 9 月,GoodRx 宣布与 MedImpact 合作,为 MedImpact 会员在药房柜台提供无缝体验。此外,此次合作将使两家公司无需任何额外努力即可为消费者节省更多成本,并提供无缝数据集成计划。这是通过 MedImpact 严格的药物安全审查确保向患者发出有关任何不良药物相互作用的警报来实现的。公司简介
Amazon.com Inc Goodrx Holdings Inc The Cigna Group CVS Health Corp Walmart Inc Hims & Hers Health Inc Roman Health Pharmacy LLC Apex Pharmacy Inc LloydsPharmacy Ltd Pharmacy2U Ltd Docmorris NV Truepill
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the key players in the US digital pharmacy market?

CVS Health Group, Cigna Group, Good Rx Holdings Inc., Walmart Inc., Hims & Hers Health Inc., Roman Health Pharmacy LLC, Apex Pharmacy Inc., Lloyds Pharmacy, Pharmacy2U Ltd., Docmorris NV, True pill among others are among the leading companies operating in the US digital pharmacy market.

Which gender segment held the largest revenue (US$ Mn) in the US digital pharmacy market?

The female segment dominated the global US digital pharmacy market and accounted for the largest revenue in 2022.

Which segment led the US digital pharmacy market?

Based on drug type, the prescription medicine segment took the forefront lead in the US digital pharmacy market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.

What are the driving factors for the US digital pharmacy market across the globe?

Upsurge in online purchase of prescription medicines during COVID-19 pandemic, increasing inclination towards online platform are the factor responsible for the overall market growth.

What is meant by the US digital pharmacy market?

A digital/online pharmacy, or mail-order pharmacy is a pharmacy that operates over the internet and directs orders to customers via mail, shipping companies, or online pharmacy web portal. Online pharmacies include pharmacy benefits managers that administrate corporate prescription drug plans.

The List of Companies - US Digital Pharmacy Market

  1. Amazon.com Inc.
  2. Good Rx Holdings
  3. The Cigna Group
  4. CVS Health Corp
  5. Walmart Inc.
  6. Hims & Hers Health Inc.
  7. Roman Health Pharmacy LLC
  8. Apex Pharmacy Inc.
  9. LloydsPharmacy Ltd.
  10. Pharmacy2U Ltd.
  11. Docmorris NV
  12. Truepill

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Healthcare IT : READ MORE..